Contraception News and Research

Latest Contraception News and Research

IOM to issue report on preventive health care services for women

IOM to issue report on preventive health care services for women

First Edition: July 19, 2011

First Edition: July 19, 2011

Thalidomide analog shows promise against sickle cell disease

Thalidomide analog shows promise against sickle cell disease

State roundup: Model insurance brings 'modest' savings

State roundup: Model insurance brings 'modest' savings

Viewpoints: Teaching hospital cuts; Medicare & debt deal politics; end-of-life care

Viewpoints: Teaching hospital cuts; Medicare & debt deal politics; end-of-life care

First Edition: July 14, 2011

First Edition: July 14, 2011

Eisai's DACOGEN sNDA for acute myeloid leukemia accepted by FDA for review

Eisai's DACOGEN sNDA for acute myeloid leukemia accepted by FDA for review

FDA accepts Eisai's DACOGEN sNDA for review to treat acute myeloid leukemia

FDA accepts Eisai's DACOGEN sNDA for review to treat acute myeloid leukemia

Many women in war-torn areas unable to obtain family planning services

Many women in war-torn areas unable to obtain family planning services

Family planning essential for meeting world population's needs

Family planning essential for meeting world population's needs

Romantic fiction bad for marriages and love life!

Romantic fiction bad for marriages and love life!

Longer looks: Shortage of HIV doctors; Oregon program builds on British model

Longer looks: Shortage of HIV doctors; Oregon program builds on British model

SOGC launches first Facebook game about healthy sexuality for Canadians

SOGC launches first Facebook game about healthy sexuality for Canadians

Conference examines family planning benefits for health

Conference examines family planning benefits for health

Focus on men in family planning programs

Focus on men in family planning programs

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Viewpoints:  Medicare eligibility age; Medicare 'scares'; questions about Fla. Medicaid managed care

Viewpoints: Medicare eligibility age; Medicare 'scares'; questions about Fla. Medicaid managed care

State roundup: Mass. health spending's rise; huge Ky. hospital merger

State roundup: Mass. health spending's rise; huge Ky. hospital merger

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.